logo

Analyst Comments: Alpharma, Hawaiian Electric, Diamond Foods, Cabela, Iconix
By: Zacks Investment Research   Tuesday, May 06, 2008 1:54 PM

Vote for next session
The next market session will close:

During Transition, Alpharma Risky

Alpharma, Inc. (ALO) is a pharmaceutical company with operations in human and animal pharmaceuticals. With the sale of the generics and API business segments, Alpharma is focusing on establishing itself as a specialty pharmaceuticals company.

We expect 2008 to be another transitional year for the company with earnings declining significantly, mainly due to increased sales, general and administrative (SG&A) spending related to the launch of Flector Patch. In the absence of any potential catalysts, investor focus will remain on the acceptance and ramp-up of Flector Patch. Although we expect earnings to rebound in 2009, we remain concerned about KadianĂ¢?s growth prospects and the sales ramp of Flector Patch.

The company recently sold its API business for $365 million. This deal makes sense, as the API business had been struggling over the past couple of years, mainly due to increased competition and pricing pressure. The sale has provided Alpharma with funds to expand its pharmaceuticals product portfolio in existing as well as new therapeutic areas.

With the loss of revenue and operating income from the API business, we expect the deal to be EPS dilutive in 2008. Based on our revised model, we see the company delivering EPS of $0.31 on revenues of $696.5 million in 2008.

Although we expect earnings to rebound in 2009, we believe that investor focus will remain on the company's ability to maintain Kadian growth and Flector Patch sales. Alpharma shares are currently trading at 82.1x our estimated calendar year 2008 EPS of $0.31. We believe the shares are over-valued at current levels. We rate the stock a Sell with a $20 price target. Our price target is based on 25.3x our 2009 EPS estimate.

Skirt Hawaiian Electric For Now

Hawaiian Electric Industries, Inc. (HE) reported consolidated net income in the first quarter of 2008 of $34 million, or $0.41 per share, compared to $6.8 million, or $0.08 per share, and $32.3 million, or $0.40 per share, for the first quarters of 2007 and 2006, respectively. Electric utility net income for the first quarter of 2008 was $24.6 million compared to $0.5 million and $21 million for the first quarters in 2007 and 2006, respectively.

Kilowatt/hour sales were flat compared with the same quarter of 2007 primarily due to conservation and demand-side management programs offsetting the impact of slightly warmer temperatures and an additional day of sales in February due to the leap year. Meanwhile, operations and maintenance expenses were up $4.7 million or 6% quarter-over-quarter and the utility expects this higher level of expense to continue due to additional planned production and transmission and distribution maintenance work. The utility also recorded $1.2 million in higher quarter-over-quarter depreciation expenses due to 2007 plant additions.


Next Page >>123

(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

The above story is the opinion of the author only and it does not reflect iStockAnalyst opinion. Further, the author is not personally advising you regarding the suitability of the story for your investment needs. In no event iStockAnalyst will be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from or arising out of, or in connection with the use of this information. Please consult your investment advisor before making any investment decision.
  
Advertisement
Popular Articles
Related Press Releases
Advertisement
Partner Center
Recent Articles by Zacks Investment Research



Subscribe to Email Alerts rss feed or RSS feeds rss feed for articles from more than 500 contributors, press releases, SEC filings and full text news from more than four thousand sources.
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia